search
Back to results

Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts

Primary Purpose

Cystic Renal Disease, Kidney Cancer, Surgery

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Delayed surgery
Immediate surgery
Sponsored by
Helsinki University Central Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cystic Renal Disease focused on measuring Bosniak classification, Active surveillance, Renal cystic mass, Cystic renal cell carcinoma

Eligibility Criteria

50 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A sporadic single CM of Bosniak 3 according to the Bosniak Classification v.2019 is diagnosed with CT or MRI
  • Maximal diameter of CM 10-70 mm
  • Age ≥50 years
  • ECOG performance status <2
  • Life expectancy ≥5 years
  • Patient is fit to undergo surgery and AS.
  • Patient understands a national language or English
  • Signed informed consent

Exclusion Criteria:

  • Genetic syndromes associated with RCC
  • Previously or simultaneously diagnosed and pathologically verified RCC
  • Previously or simultaneously radiographically identified solid mass or CM of Bosniak 3/4 with diameter ≥10mm
  • The target CM of Bosniak 3 has progressed in sequential imaging from Bosniak 1-2F
  • Presence of radiographic findings which are suspect for nodal or distant metastatic disease
  • Symptomatic CM
  • Kidney insufficiency (GFR<55 ml/min/1,73m2)
  • Patients who have contraindications for both CT and MRI imaging. . Anatomically solitary kidney

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Immediate surgery

    Active surveillance

    Arm Description

    Patients undergo excision of a renal mass by partial or radical nephrectomy and will be followed by UISS risk classification.

    Patients enter active surveillance protocol. Delayed surgery on active surveillance will be recommended if progression from Bosniak 3 to 4 or a solid mass is noted on imaging by radiologist

    Outcomes

    Primary Outcome Measures

    Malignancy rate in surgical pathology

    Secondary Outcome Measures

    Cancer specific survival
    Progression-free survival
    Overall survival

    Full Information

    First Posted
    November 26, 2020
    Last Updated
    February 16, 2021
    Sponsor
    Helsinki University Central Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04670887
    Brief Title
    Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts
    Official Title
    A Prospective Multicenter Trial Comparing Surgery Versus Active Surveillance In Patients With Bosniak 3 Renal Cystic Masses, A NoRenCa And FinnKidney Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2020
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    March 15, 2021 (Anticipated)
    Primary Completion Date
    January 11, 2024 (Anticipated)
    Study Completion Date
    January 11, 2036 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Helsinki University Central Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The incidence of renal cysts is rising due to increased abdominal imaging. Renal complicated cysts have been traditionally classified according to the Bosniak classification, which distinguishes cystic masses by specific features of walls and septa. The categories I and II are benign and class IIF most probably benign but needs a short radiological follow-up. Categories III and IV have been traditionally operated due to the increased risk of renal cell carcinoma. However, recently published studies show that approximately 50% of the operated Bosniak III cystic masses are benign, which means that half of the cases are overtreated by surgery. It has also been shown that surgical pathology of stable Bosniak IIF cysts is malignant in less than 1%, while the cysts, which are upgraded to higher Bosniak classes will show malignant surgical pathology in 85%. So far, there is lack of prospective data on active surveillance in Bosniak III cystic masses. The aim of the study is to compare active surveillance and surgery in patients with Bosniak III renal cystic masses. Patients will be randomized in active surveillance or immediate surgical excision of a cystic mass. In the active surveillance group, patients are followed according to the study protocol for 10 years and treated with delayed surgery if the cystic mass upgrades into Bosniak IV/solid, becomes symptomatic or grows over a preclassified threshold. The primary objective is to compare surgical pathology between patients treated with immediate surgery versus delayed surgery. According to recent retrospective data, active surveillance of Bosniak III cystic masses is reasonable and oncologically safe. Therefore a prospective randomized controlled trial is needed to get high level evidence to support a change in the treatment strategy. The study may significantly reduce unnecessary operations performed in patients with Bosniak III cystic masses.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cystic Renal Disease, Kidney Cancer, Surgery
    Keywords
    Bosniak classification, Active surveillance, Renal cystic mass, Cystic renal cell carcinoma

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    200 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Immediate surgery
    Arm Type
    Active Comparator
    Arm Description
    Patients undergo excision of a renal mass by partial or radical nephrectomy and will be followed by UISS risk classification.
    Arm Title
    Active surveillance
    Arm Type
    Active Comparator
    Arm Description
    Patients enter active surveillance protocol. Delayed surgery on active surveillance will be recommended if progression from Bosniak 3 to 4 or a solid mass is noted on imaging by radiologist
    Intervention Type
    Procedure
    Intervention Name(s)
    Delayed surgery
    Intervention Description
    Delayed surgery is performed if cystic mass radiologically upgrades into Bosniak 4 or solid mass in the active surveillance.
    Intervention Type
    Procedure
    Intervention Name(s)
    Immediate surgery
    Intervention Description
    Partial or radical nephrectomy is performed as treatment of Bosniak 3 cystic mass
    Primary Outcome Measure Information:
    Title
    Malignancy rate in surgical pathology
    Time Frame
    From date of randomization until the date of surgery, assessed up to 120 months
    Secondary Outcome Measure Information:
    Title
    Cancer specific survival
    Time Frame
    From date of randomization until the date of death due to renal cancer, assessed up to 120 months
    Title
    Progression-free survival
    Time Frame
    From date of randomization until the date of first documented progression, assessed up to 120 months
    Title
    Overall survival
    Time Frame
    From date of randomization until the date of death from any cause, assessed up to 120 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    50 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: A sporadic single CM of Bosniak 3 according to the Bosniak Classification v.2019 is diagnosed with CT or MRI Maximal diameter of CM 10-70 mm Age ≥50 years ECOG performance status <2 Life expectancy ≥5 years Patient is fit to undergo surgery and AS. Patient understands a national language or English Signed informed consent Exclusion Criteria: Genetic syndromes associated with RCC Previously or simultaneously diagnosed and pathologically verified RCC Previously or simultaneously radiographically identified solid mass or CM of Bosniak 3/4 with diameter ≥10mm The target CM of Bosniak 3 has progressed in sequential imaging from Bosniak 1-2F Presence of radiographic findings which are suspect for nodal or distant metastatic disease Symptomatic CM Kidney insufficiency (GFR<55 ml/min/1,73m2) Patients who have contraindications for both CT and MRI imaging. . Anatomically solitary kidney
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Harry Nisén, Adj. professor
    Phone
    +35894711
    Email
    harry.nisen@hus.fi
    First Name & Middle Initial & Last Name or Official Title & Degree
    Juhana Rautiola
    Phone
    +35894711
    Email
    juhana.rautiola@hus.fi
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Harry Nisén
    Organizational Affiliation
    Helsinki University Central Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    All IPD that underlie results in a publication.
    IPD Sharing Time Frame
    Starting 6 months after publication.
    IPD Sharing Access Criteria
    Requests are reviewed by the steering committee.

    Learn more about this trial

    Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts

    We'll reach out to this number within 24 hrs